Solid Biosciences Inc. SLDB Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $297.1M+396% | $59.9M-2.4% | $61.36M-55.8% | $138.93M-34.0% | $210.63M+163% | ||
| $83.58M-34.7% | $127.95M-26.8% | $174.78M+35.3% | $129.18M+34.2% | $96.29M+40.2% | ||
| $638K-47.8% | $1.22M-36.5% | $1.92M0.0% | $1.92M— | $0— | ||
| $15.47M-5.6% | $16.38M+88.1% | $8.71M-17.3% | $10.53M+62.2% | $6.49M-22.6% | ||
| $396.79M+93.1% | $205.46M-16.1% | $244.85M-12.1% | $278.64M-11.1% | $313.41M+99.2% | ||
| $3.91M-6.1% | $4.17M-4.3% | $4.36M+0.9% | $4.32M-3.7% | $4.48M-5.6% | ||
| $21.3M-2.8% | $21.92M-2.7% | $22.54M-2.6% | $23.13M-2.5% | $23.72M-2.4% | ||
| $183K-17.9% | $223K-9.7% | $247K-11.2% | $278K-12.9% | $319K-12.8% | ||
| $26.11M-3.6% | $27.08M-6.8% | $29.06M-2.0% | $29.65M-2.8% | $30.5M-2.8% | ||
| $422.89M+81.9% | $232.54M-15.1% | $273.91M-11.2% | $308.29M-10.4% | $343.9M+82.3% | ||
| $5.56M+72.5% | $3.22M-61.8% | $8.43M+79.2% | $4.7M-26.9% | $6.44M+52.0% | ||
| $19.18M+1.3% | $18.95M-0.6% | $19.05M+15.1% | $16.55M+13.5% | $14.58M-26.6% | ||
| $2.19M+4.0% | $2.1M+3.5% | $2.03M+4.6% | $1.94M+4.0% | $1.87M+4.5% | ||
| $30.28M-9.5% | $33.47M-7.9% | $36.34M+21.8% | $29.85M+3.7% | $28.78M-4.9% | ||
| $18.48M-3.0% | $19.06M-2.9% | $19.62M-2.6% | $20.16M-2.5% | $20.66M-2.3% | ||
| —— | —— | —— | —— | —— | ||
| $18.48M-3.0% | $19.06M-2.9% | $19.62M-2.6% | $20.16M-2.5% | $20.66M-2.3% | ||
| $48.76M-7.2% | $52.53M-6.1% | $55.97M+11.9% | $50M+1.1% | $49.44M-3.8% | ||
| —— | —— | —— | —— | —— | ||
| $98K+24.1% | $79K+1.3% | $78K0.0% | $78K+1.3% | $77K+92.5% | ||
| $1.39B+22.1% | $1.14B+1.1% | $1.13B+0.5% | $1.12B+0.3% | $1.12B+21.3% | ||
| -$1.01B-5.9% | -$957.78M-5.5% | -$907.99M-5.3% | -$862.21M-4.8% | -$822.73M-5.0% | ||
| -$13K-125% | $52K+8.3% | $48K+226% | -$38K-2,000% | $2K-95.7% | ||
| $374.13M+108% | $180.01M-17.4% | $217.95M-15.6% | $258.29M-12.3% | $294.46M+115% | ||
| $422.89M+81.9% | $232.54M-15.1% | $273.91M-11.2% | $308.29M-10.4% | $343.9M+82.3% | ||
| $83.58M-34.7% | $127.95M-26.8% | $174.78M+35.3% | $129.18M+34.2% | $96.29M+40.2% | ||
| $183K-17.9% | $223K-9.7% | $247K-11.2% | $278K-12.9% | $319K-12.8% | ||
| $21.3M-2.8% | $21.92M-2.7% | $22.54M-2.6% | $23.13M-2.5% | $23.72M-2.4% | ||
| $21.3M-2.8% | $21.92M-2.7% | $22.54M-2.6% | $23.13M-2.5% | $23.72M-2.4% | ||
| $183K-17.9% | $223K-9.7% | $247K-11.2% | $278K-12.9% | $319K-12.8% | ||
| $21.3M-2.8% | $21.92M-2.7% | $22.54M-2.6% | $23.13M-2.5% | $23.72M-2.4% | ||
| $183K-17.9% | $223K-9.7% | $247K-11.2% | $278K-12.9% | $319K-12.8% | ||
| $19.18M+1.3% | $18.95M-0.6% | $19.05M+15.1% | $16.55M+13.5% | $14.58M-26.6% | ||
| $19.18M+1.3% | $18.95M-0.6% | $19.05M+15.1% | $16.55M+13.5% | $14.58M-26.6% | ||
| $3.35M-63.6% | $9.2M+40.5% | $6.55M+14.9% | $5.7M+18.8% | $4.8M+52.4% | ||
| $3.35M-63.6% | $9.2M+40.5% | $6.55M+14.9% | $5.7M+18.8% | $4.8M+52.4% | ||
| $20.67M-2.3% | $21.16M-3.5% | $21.94M-4.8% | $23.05M-2.4% | $23.63M-2.3% | ||
| $1.39B+22.1% | $1.14B+1.1% | $1.13B+0.5% | $1.12B+0.3% | $1.12B+21.3% | ||
| $98K+24.1% | $79K+1.3% | $78K0.0% | $78K+1.3% | $77K+92.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Solid Biosciences Inc.'s total assets?
- Solid Biosciences Inc. (SLDB) holds $422.9M in total assets, up 23.0% year over year.
- How much debt does Solid Biosciences Inc. have?
- Solid Biosciences Inc. carries $20.7M in total debt against $374.1M of shareholders' equity, a debt-to-equity ratio of 0.06.
- How much cash does Solid Biosciences Inc. have?
- Solid Biosciences Inc. holds $297.1M in cash and equivalents.
- Can Solid Biosciences Inc. cover its short-term obligations?
- Its current ratio is 13.10 — current assets exceed current liabilities.
- Where does Solid Biosciences Inc.'s balance sheet data come from?
- Every line is extracted from Solid Biosciences Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
